These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17210586)

  • 1. Pharmacoeconomics in nephrology: considerations on cost-effectiveness of screening for albuminuria.
    Postma MJ; Boersma C; Gansevoort RT
    Nephrol Dial Transplant; 2008 Apr; 23(4):1103-6. PubMed ID: 17210586
    [No Abstract]   [Full Text] [Related]  

  • 2. Microalbuminuria: accuracy or economics.
    Lewis JB
    Am J Kidney Dis; 1998 Sep; 32(3):524-8. PubMed ID: 9740175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Routine screening for microalbuminemia in type 2 diabetes mellitus--con].
    Sawicki PT
    Dtsch Med Wochenschr; 2003 May; 128(21):1188. PubMed ID: 12761693
    [No Abstract]   [Full Text] [Related]  

  • 4. [Routine screening for microalbuminemia in type 2 diabetes mellitus--pro].
    Dikow R; Ritz E
    Dtsch Med Wochenschr; 2003 May; 128(21):1187. PubMed ID: 12761692
    [No Abstract]   [Full Text] [Related]  

  • 5. The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus.
    Postma MJ; de Zeeuw D
    Nephrol Dial Transplant; 2009 Oct; 24(10):2975-83. PubMed ID: 19605601
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis, implication, prevention and treatment of microalbuminuria].
    Schmieder RE; Bramlage P
    Dtsch Med Wochenschr; 2012 Jul; 137(27):1409-16; quiz 1417-8. PubMed ID: 22736183
    [No Abstract]   [Full Text] [Related]  

  • 7. [The kidneys and diabetes].
    Rüster C; Sämann A; Wolf G
    Dtsch Med Wochenschr; 2008 Sep; 133(37):1848-52. PubMed ID: 18770486
    [No Abstract]   [Full Text] [Related]  

  • 8. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 9. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of screening for and treating albuminuria in individuals without diabetes or hypertension: are we moving beyond the evidence?
    Mangione F; Esposito C; Dal Canton A
    Am J Kidney Dis; 2010 Oct; 56(4):801; author reply 801-2. PubMed ID: 20851319
    [No Abstract]   [Full Text] [Related]  

  • 11. [Economic evaluation of drugs. Effectiveness in diabetes therapy].
    Schöffski O
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S106-9; discussion S124-6. PubMed ID: 18686218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How Germany manages it's diabetic patients].
    Einecke D
    MMW Fortschr Med; 1999 Oct; 141(42):4-5. PubMed ID: 10912093
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H; Sone H; Oishi M; Kawai K; Fukumoto Y; Kobayashi M;
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy: introduction.
    Breyer MD
    Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening, monitoring, and treatment of albuminuria: Public health perspectives.
    de Jong PE; Curhan GC
    J Am Soc Nephrol; 2006 Aug; 17(8):2120-6. PubMed ID: 16825331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 17. Status and rationale of renoprotection studies in adolescents with type 1 diabetes.
    Marcovecchio ML; Tossavainen PH; Dunger DB
    Pediatr Diabetes; 2009 Aug; 10(5):347-55. PubMed ID: 19496962
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of insulin analogs.
    Brixner DI; McAdam-Marx C
    Am J Manag Care; 2008 Nov; 14(11):766-75. PubMed ID: 18999911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic nephropathy].
    Morcos M; Zeier M; Schwenger V
    Dtsch Med Wochenschr; 2007 May; 132(19):1039-42. PubMed ID: 17476634
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinopathy and macro-albuminuria in type 2 diabetic patients.
    Phoksunthorn T; Thatsnarong D
    J Med Assoc Thai; 2007 Apr; 90(4):684-7. PubMed ID: 17487122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.